Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Volitionrx (VNRX) Accumulated Expenses (2019 - 2025)

Volitionrx's Accumulated Expenses history spans 7 years, with the latest figure at $4.2 million for Q4 2025.

  • For Q4 2025, Accumulated Expenses rose 21.14% year-over-year to $4.2 million; the TTM value through Dec 2025 reached $4.2 million, up 21.14%, while the annual FY2025 figure was $4.2 million, 21.14% up from the prior year.
  • Accumulated Expenses reached $4.2 million in Q4 2025 per VNRX's latest filing, down from $4.6 million in the prior quarter.
  • In the past five years, Accumulated Expenses ranged from a high of $4.6 million in Q3 2025 to a low of $2.7 million in Q1 2023.
  • Average Accumulated Expenses over 5 years is $3.5 million, with a median of $3.5 million recorded in 2024.
  • Peak YoY movement for Accumulated Expenses: fell 24.98% in 2022, then skyrocketed 36.78% in 2023.
  • A 5-year view of Accumulated Expenses shows it stood at $3.8 million in 2021, then fell by 24.98% to $2.9 million in 2022, then skyrocketed by 36.78% to $3.9 million in 2023, then dropped by 11.5% to $3.5 million in 2024, then rose by 21.14% to $4.2 million in 2025.
  • Per Business Quant, the three most recent readings for VNRX's Accumulated Expenses are $4.2 million (Q4 2025), $4.6 million (Q3 2025), and $4.4 million (Q2 2025).